Palliation of AIDS-related primary lymphoma of the brain: observations from a multi-institutional database.
OBJECTIVE
To catalogue the presenting symptoms of patients with AIDS who are presumed to have primary central nervous system lymphoma (PCNSL). To document the palliative efficacy of cranial irradiation (RT) relative to the endpoints of complete and overall response for the respective symptoms.


METHODS
An analysis of 163 patients with AIDS-related PCNSL who were evaluated at nine urban hospitals was performed. These patients were treated for PCNSL after the establishment of a tissue diagnosis or on a presumptive basis after failing empiric treatment for toxoplasmosis. All patients were treated between 1983 and 1995 with radiotherapy (median dose-fractionation scheme = 3 Gy x 10) and steroids (>90% dexamethasone). Because multiple fractionation schemes were used, prescriptions were converted to biologically effective doses according to the formula, Gy10 = Total Dose x (1 + fractional dose/alpha-beta); using an alpha-beta value of 10.


RESULTS
The overall palliative response rate for the entire group was 53%. In univariate analysis, trends were present associating complete response rates with higher performance status (KPS > or = 70 vs. KPS < or = 60 = 17% vs. 5%), female gender (women vs. men = 29% vs. 8%), and the delivery of higher biologically effective doses (BED) of RT (Gy10 > 39 vs. < or = 39 = 20% vs. 5%). In multivariate analysis of factors predicting complete response, both higher KPS and higher BED retained independent significance. A separate univariate analysis identified high performance status (KPS > or = 70 vs. KPS < or = 60 = 71% vs. 47%), and young age (< or = 35 vs. > 35 = 61% vs. 40%) as factors significantly correlating with the endpoint of the overall response. In multivariate analysis, high performance status and the delivery of higher biologically effective doses of irradiation correlated significantly with higher overall response rates.


CONCLUSIONS
Most AIDS patients who develop symptoms from primary lymphoma of the brain can achieve some palliation from a management program that includes cranial irradiation. Young patients with excellent performance status are most likely to respond to treatment. The delivery of higher biologically effective doses of irradiation also may increase the probability of achieving a palliative response.
Corn
B W
BW
Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
Donahue
B R
BR
Rosenstock
J G
JG
Cooper
J S
JS
Xie
Y
Y
Brandon
A H
AH
Hegde
H H
HH
Sherr
D L
DL
Fisher
S A
SA
Berson
A
A
Han
H
H
Abdel-Wahab
M
M
Koprowski
C D
CD
Ruffer
J E
JE
Curran
W J
WJ
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000293:Adolescent; D000328:Adult; D000368:Aged; D016371:Cranial Irradiation; D005260:Female; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D010166:Palliative Care; D012307:Risk Factors; D015819:Substance Abuse, Intravenous / Q000150:complications